fbpx

YOUR GUIDE TO STAYING INFORMED IN THE MARKETS

Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Walgreens Diversifying Into Clinical Trials Business- $WBA $DIA

By John F. Heerdink, Jr.

As per reports, Walgreen Boots Alliance (WBA) launched a clinical trials business that aims to use patient data from its pharmacies to help boost recruitment in studies conducted by drugmakers. Last year, Walgreens invested $5.5 billion to take majority stakes in two health care providers, VillageMD and CareCentrix looking to expand beyond its core business.

The company is focused to use its vast data and new services to help cut costs for drugmakers with the clinical trials business, and capture a share of the roughly $83 billion markets.

“This is yet another way we are building our next growth engine of consumer-centric healthcare solutions,” stated Ramita Tandon, Walgreen’s chief clinical trials officer.
 

Walgreen Boots Alliance (WBA) is a pharmacy-led, health and well-being enterprise with a long history of trusted healthcare services, community pharmacy care, and pharmaceutical wholesaling dates. To learn more about Walgreen Boots Alliance (WBA) and to continue to track its progress please visit the Vista Partners Walgreens Boots Alliance Page.

Walgreens Boots Alliance and McKesson to Create German Wholesale Joint Venture


Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.

Stay Informed! Stay Competitive! Please join us at Vista Partners, receive our FREE email updates throughout the week, and view our exclusive content and research.

 
(Read Original Story: Walgreens enters clinical trials business through new unit in Reuters)


YOUR GUIDE TO STAYING INFORMED IN THE MARKETS

Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us